InclineRx LLC – Trademark Portfolio

Entity Type: 16

InclineRx LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 3 filings in this category. The portfolio also extends into Class 28 (Toys & Sporting Goods) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include LULL. The owner is based in Seattle, WA.

6533 31st Ave NE

Seattle, WA 98115

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LULL
LULL
Registered 2019

Trademark Classifications

InclineRx LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

28
Toys & Sporting Goods (3 filings)

Games and playthings; gymnastic and sporting articles; decorations for Christmas trees

20
Furniture (2 filings)

Furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker

Frequently Asked Questions

How many trademarks does InclineRx LLC have?

InclineRx LLC has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 cancelled.

What trademark classes does InclineRx LLC file in?

InclineRx LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 28 (Toys & Sporting Goods), Class 20 (Furniture). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are InclineRx LLC's most well-known trademarks?

InclineRx LLC's registered trademark portfolio includes well-known marks such as LULL. These are among 1 currently registered trademark in the portfolio.

What is InclineRx LLC's trademark registration success rate?

InclineRx LLC has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.